Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296114 · ClinicalTrials.gov registry record
Pancreatic Cancer Serum and DNA Repository
A clinical trial, sponsored by Pancreatic Cancer Research Team.
- Completed
- Registry status
- 690
- Enrollment target
NCT00296114: Completed study, sponsored by Pancreatic Cancer Research Team.
NCT00296114 is a clinical trial that has completed, run by Pancreatic Cancer Research Team. The registered enrollment target is 690 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00296114 has completed, sponsored by Pancreatic Cancer Research Team.
- COMPLETED
- Registry status
- 690 participants
- Enrollment target
Study Summary
To prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify novel biomarkers for early diagnosis, differential diagnosis, stage, natural history of the disease, response to treatment, and to identify novel targets for therapeutic interventions. In particular:
Interventions
- PROCEDURE Serum and DNA Samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 690 participants |
| Start Date | 2004-02 |
| Est. Completion | 2011-12 |
What the finished NCT00296114 record still lists
NCT00296114 is an observational study that tracks outcomes without assigning an intervention. The registered 690 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Serum and DNA Samples is the first listed.
NCT00296114 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00296114 about?
NCT00296114 is a clinical study titled "Pancreatic Cancer Serum and DNA Repository". To prospectively collect serum and DNA samples from subjects with pancreatic cancer, pancreatitis, liver disease, and from healthy and at-risk volunteers in order to identify novel biomarkers for early diagnosis, differential diagnosis, stage, natural history of the disease, response to treatment, a...
What is the current status of trial NCT00296114?
This trial is currently completed. The enrollment target is 690 participants. The study started on 2004-02. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00296114?
The interventions under investigation include: Serum and DNA Samples (PROCEDURE).
Who is sponsoring clinical trial NCT00296114?
This trial is sponsored by Pancreatic Cancer Research Team, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00532051 · 690 participants
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
- NCT05184335 · 690 participants · Phase 3
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
- NCT07221149 · 690 participants · Phase 2
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- NCT07382167 · 692 participants · Phase 3
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia